Entries of Venkataramana, N. K. on the publication server

Bogdahn, Ulrich, Hau, Peter, Stockhammer, G., Venkataramana, N. K., Mahapatra, A. K., Suri, A., Balasubramaniam, A., Nair, S., Oliushine, V., Parfenov, V., Poverennova, I., Zaaroor, M., Jachimczak, P., Ludwig, S., Schmaus, S., Heinrichs, H. and Schlingensiepen, K. H. (2011) Targeted therapy for high-grade glioma with the TGF-β2 inhibitor trabedersen: results of a randomized and controlled phase IIb study. Neuro-oncology 13 (1), pp. 132-142. Fulltext not available.

Bogdahn, U., Stockhammer, G., Mahapatra, A. K., Venkataramana, N. K., Oliushine, V. E., Parfenov, V. E., Poverennova, I. E., Jachimczak, P., Heinrichs, H. and Schlingensiepen, K. (2010) Pseudoprogression after treatment with the TGF-beta 2 inhibitor trabedersen in high-grade glioma patients. Journal of Clinical Oncology 28 (15_sup), p. 2054. Fulltext not available.

Bogdahn, U., Hau, P., Olyushin, V., Mahapatra, A. K., Parfenov, V., Venkataramana, N. K., Wassmann, H., Ludwig, S., Heinrichs, H. and Schlingensiepen, K. H. (2008) Targeted therapy with AP 12009 in recurrent or refractory glioblastoma patients: Results of a phase Iib study. Journal of Clinical Oncology 26 (15_sup), p. 2018. Fulltext not available.